PURGING OF LEUKEMIC BONE MARROW WITH ANTISENSE DNA

用反义 DNA 清除白血病骨髓

基本信息

  • 批准号:
    3034746
  • 负责人:
  • 金额:
    $ 3.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-12-01 至
  • 项目状态:
    未结题

项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Selina M Luger其他文献

Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience
  • DOI:
    10.1182/blood-2023-186978
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Margaret Rowe;Daria V Babushok;Martin Carroll;Alison Carulli;Noelle V. Frey;Saar Gill;Elizabeth O Hexner;Rebecca Hirsh;Nasheed Hossain;Catherine Lai;Alison W Loren;Selina M Luger;Ivan Maillard;Shannon R McCurdy;Andrew H Matthews;Mary Ellen Martin;Vikram R Paralkar;Alexander Perl;David L. Porter;Keith W Pratz
  • 通讯作者:
    Keith W Pratz
Evolving Racial/Ethnic Disparities in AML Survival in the Novel Therapy Era: Real-World Evidence of Improved Survival in Older Patients with the Largest Improvement in Non-Hispanic Black Patients
  • DOI:
    10.1182/blood-2023-180185
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Xin Wang;Phyllis Gimotty;Andrew H Matthews;Ronac Mamtani;Selina M Luger;Elizabeth O Hexner;Daria V Babushok;Shannon R McCurdy;Noelle V. Frey;Ximena Jordan Bruno;David L. Porter;Saar Gill;Mary Ellen Martin;Vikram R Paralkar;Ivan Maillard;Alison W Loren;Alexander Perl;Keith W Pratz;Kelly D. Getz;Catherine Lai
  • 通讯作者:
    Catherine Lai
Hypomethylating Agents Are Associated with High Rates of Hematologic Toxicity in Patients with Secondary MDS/AML That Develops after Acquired Aplastic Anemia
  • DOI:
    10.1182/blood-2023-179383
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Matthew P Connor;Neeharika Prathapa;Noelle V. Frey;Saar Gill;Elizabeth O Hexner;Ximena Jordan Bruno;Catherine Lai;Alison W Loren;Selina M Luger;Andrew H Matthews;Shannon R McCurdy;Alexander Perl;David L. Porter;Arlene Zeringue;Joseph H. Oved;Timothy S Olson;Keith W Pratz;Daria V Babushok
  • 通讯作者:
    Daria V Babushok
Frail and Pre-Frail Older Adults with Acute Myeloid Leukemia Have Inferior Survival Due to Higher Rates of Disease-Related Deaths
  • DOI:
    10.1182/blood-2023-188978
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Ashley D Hadjis;Griffin W White;Christopher Catania;Noelle V. Frey;Saar Gill;Elizabeth O Hexner;Ximena Jordan Bruno;Catherine Lai;Andrew H Matthews;Mary Ellen Martin;Daria V Babushok;Alexander Perl;David L. Porter;Alison W Loren;Keith W Pratz;Selina M Luger;Shannon R McCurdy
  • 通讯作者:
    Shannon R McCurdy
Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial
  • DOI:
    10.1182/blood-2023-189734
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    James M. Foran;Li Chen;Selina M Luger;Zhuoxin Sun;Heidi Klepin;David F. Claxton;Hillard M. Lazarus;Jacob M. Rowe;Jessica K. Altman;Aref Al-Kali;Hong Zheng;Keith W Pratz;Edward R. Broun;Bayard L Powell;Kristen M. O'Dwyer;Yishai Ofran;John E. Godwin;Mark R. Litzow;Martin S. Tallman;Lynne Wagner
  • 通讯作者:
    Lynne Wagner

Selina M Luger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Selina M Luger', 18)}}的其他基金

C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
C-MYB 反义寡脱氧核苷酸在慢性粒细胞白血病患者中的应用
  • 批准号:
    6565773
  • 财政年份:
    2001
  • 资助金额:
    $ 3.25万
  • 项目类别:
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE
自体骨髓移植:C-MYB 反义寡脱氧核苷酸
  • 批准号:
    6565777
  • 财政年份:
    2001
  • 资助金额:
    $ 3.25万
  • 项目类别:
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
C-MYB 反义寡脱氧核苷酸在慢性粒细胞白血病患者中的应用
  • 批准号:
    6468023
  • 财政年份:
    2000
  • 资助金额:
    $ 3.25万
  • 项目类别:
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE
自体骨髓移植:C-MYB 反义寡脱氧核苷酸
  • 批准号:
    6468027
  • 财政年份:
    2000
  • 资助金额:
    $ 3.25万
  • 项目类别:
PURGING OF LEUKEMIC BONE MARROW WITH ANTISENSE DNA
用反义 DNA 清除白血病骨髓
  • 批准号:
    2085207
  • 财政年份:
    1993
  • 资助金额:
    $ 3.25万
  • 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
  • 批准号:
    8304351
  • 财政年份:
    1978
  • 资助金额:
    $ 3.25万
  • 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
  • 批准号:
    8651973
  • 财政年份:
    1978
  • 资助金额:
    $ 3.25万
  • 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
  • 批准号:
    8100410
  • 财政年份:
    1978
  • 资助金额:
    $ 3.25万
  • 项目类别:

相似海外基金

Bioengineering Leukemic Bone Marrow Niche for Dissecting the Heterogeneous Leukemia Chemo-resistance Mechanisms
用于剖析异质性白血病化疗耐药机制的生物工程白血病骨髓生态位
  • 批准号:
    2103219
  • 财政年份:
    2021
  • 资助金额:
    $ 3.25万
  • 项目类别:
    Standard Grant
Investigating resident macrophages in the leukemic bone marrow niche by probing the CD82-DARC axis
通过探测 CD82-DARC 轴来研究白血病骨髓生态位中的常驻巨噬细胞
  • 批准号:
    466959
  • 财政年份:
    2021
  • 资助金额:
    $ 3.25万
  • 项目类别:
    Studentship Programs
Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target?
骨髓白血病微环境中的血管重塑:治疗目标?
  • 批准号:
    10371023
  • 财政年份:
    2020
  • 资助金额:
    $ 3.25万
  • 项目类别:
Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target?
骨髓白血病微环境中的血管重塑:治疗目标?
  • 批准号:
    10094210
  • 财政年份:
    2020
  • 资助金额:
    $ 3.25万
  • 项目类别:
Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target?
骨髓白血病微环境中的血管重塑:治疗目标?
  • 批准号:
    10600088
  • 财政年份:
    2020
  • 资助金额:
    $ 3.25万
  • 项目类别:
Regulation of the guanine nucleotide exchange factor DOCK1 through interaction of leukemic cells and the bone marrow niche: pathway analysis and investigation of functional aspects in acute myeloid leukemia
通过白血病细胞和骨髓生态位的相互作用调节鸟嘌呤核苷酸交换因子 DOCK1:急性髓性白血病功能方面的途径分析和研究
  • 批准号:
    324636869
  • 财政年份:
    2016
  • 资助金额:
    $ 3.25万
  • 项目类别:
    Research Grants
Dissecting early and progressive leukemogenic impairments in the hematopoietic hierarchy and function using pre-leukemic inherited bone marrow failure syndromes as human disease models
使用白血病前遗传性骨髓衰竭综合征作为人类疾病模型,剖析造血层次和功能中的早期和进行性白血病损伤
  • 批准号:
    357473
  • 财政年份:
    2016
  • 资助金额:
    $ 3.25万
  • 项目类别:
    Operating Grants
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
白血病骨髓中细胞因子-Ras 信号的分子理解
  • 批准号:
    9296107
  • 财政年份:
    2015
  • 资助金额:
    $ 3.25万
  • 项目类别:
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
白血病骨髓中细胞因子-Ras 信号的分子理解
  • 批准号:
    9103012
  • 财政年份:
    2015
  • 资助金额:
    $ 3.25万
  • 项目类别:
Molecular understanding of leukemic bone marrow cytokine-Ras signals and metabolic dependence
白血病骨髓细胞因子-Ras 信号和代谢依赖性的分子理解
  • 批准号:
    10545014
  • 财政年份:
    2015
  • 资助金额:
    $ 3.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了